tiprankstipranks
JW (Cayman) Therapeutics Co. Ltd. (HK:2126)
:2126
2126
JW (Cayman) Therapeutics Co. Ltd.
RESEARCH TOOLSreports
Want to see HK:2126 full AI Analyst Report?

JW (Cayman) Therapeutics Co. Ltd. (2126) Revenue

0 Followers
StatisticsMarket CapRevenue

JW (Cayman) Therapeutics Co. Ltd. Revenue

JW (Cayman) Therapeutics Co. Ltd. had a revenue of 174.35M in the quarter ending Dec 31, 2025, with 63.94%. This bring the company's revenue in the last twelve months to 280.69M, Decreased 57.92%. In the fiscal year ending Dec 31, 2025, JW (Cayman) Therapeutics Co. Ltd. had annual revenue of 276.31M with 74.64% growth.
Revenue (ttm)
280.69M
Revenue Growth
79.76%
P/S Ratio
3.11
Revenue/Employee
HK$983,316
Employees
281
Market Cap
HK$858.46M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
276.31M118.09M+74.64%
Dec 31, 2024
158.22M-15.64M-8.99%
Dec 31, 2023
173.86M28.15M+19.32%
Dec 31, 2022
145.70M114.91M+373.10%
Dec 31, 2021
30.80M―+∞%
Dec 31, 2020
―-5.48M-100.00%
Dec 31, 2019
5.48M5.27M+2,450.23%
Dec 31, 2018
215.00K――